How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

11,173 results for

Headache in Pregnancy

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

61. Headache in Pregnancy: An Approach to Emergency Department Evaluation and Management Full Text available with Trip Pro

Headache in Pregnancy: An Approach to Emergency Department Evaluation and Management Headache is a common presenting complaint in the emergency department. The differential diagnosis is broad and includes benign primary causes as well as ominous secondary causes. The diagnosis and management of headache in the pregnant patient presents several challenges. There are important unique considerations regarding the differential diagnosis, imaging options, and medical management. Physiologic changes (...) induced by pregnancy increase the risk of cerebral venous thrombosis, dissection, and pituitary apoplexy. Preeclampsia, a serious condition unique to pregnancy, must also be considered. A high index of suspicion for carbon monoxide toxicity should be maintained. Primary headaches should be a diagnosis of exclusion. When advanced imaging is indicated, magnetic resonance imaging (MRI) should be used, if available, to reduce radiation exposure. Contrast agents should be avoided unless absolutely

2015 Western Journal of Emergency Medicine

62. The Role of Headache in the Classification and Management of Hypertensive Disorders in Pregnancy. (Abstract)

The Role of Headache in the Classification and Management of Hypertensive Disorders in Pregnancy. Hypertensive disorders of pregnancy remain among the leading causes of maternal morbidity and mortality. The onset of headaches in patients with hypertensive disorders of pregnancy has been considered as a premonitory symptom for eclampsia and other adverse maternal outcomes. Headaches are very common symptoms during pregnancy and the postpartum period with a reported incidence of 39%; however (...) , headache is absent in 30-50% of women before the onset of eclampsia and is a poor predictor of eclampsia and adverse maternal outcomes. If included in the definition of cerebral or visual disturbances, headache may be considered a symptom of preeclampsia, a diagnostic feature of preeclampsia with severe features, a premonitory symptom of eclampsia, and an indication for delivery. Inclusion of this nonspecific symptom in the diagnosis and management of hypertensive disorders of pregnancy in the absence

2015 Obstetrics and Gynecology

63. Coronavirus (COVID-19) infection and pregnancy

professionals based on a combination of available evidence, good practice and expert consensus opinion. The priorities are: (i) The reduction of transmission of COVID-19 to pregnant women. (ii) The provision of safe, personalised and woman-centred care during pregnancy, birth and the early postnatal period during the COVID-19 pandemic. (iii) The provision of safe, personalised and woman-centred care to pregnant and postnatal women with suspected/confirmed COVID-19. Please be aware that this is very much (...) clinical advice or information for specific organisational requirements via this email address. Information for pregnant women and their families is available in question and answer format, with accompanying videos in some cases, on the RCOG COVID-19 hub. 1.1 Identification and assessment of evidence This guidance document is updated regularly following a review of the evolving literature during this pandemic. Weekly literature reviews are generated using the following search terms, MESH headings

2020 Royal College of Obstetricians and Gynaecologists

64. Coronavirus (COVID-19) infection and pregnancy

with or for COVID-19. 15 Similar findings were reported in a large systematic review of 2,567 pregnancies with COVID-19, where 50.8% of women were from a BAME background. 38.2% of the women were obese and 32.5% had chronic comorbidities such as asthma and hypertension. 28 The association with BAME is particularly apparent and echoes previous findings that UK BAME pregnant women generally have worse outcomes in pregnancy and birth. 23 Furthermore, 13% of the UK’s total population identifies as being from a BAME (...) affects 5% of pregnant women in the UK, with the majority (88%) of women with diabetes in pregnancy affected by gestational diabetes. 39 In the UKOSS study, comorbidities such as diabetes were associated with pregnant women being admitted to hospital with COVID-19. 15 In non-pregnant individuals, a UK study of 20,133 patients admitted to high dependency and intensive care with COVID-19 found uncomplicated diabetes was one of the most common comorbidities (21%, 3650/17599); a further 7% (n=1299

2020 Royal College of Obstetricians and Gynaecologists

65. NZSHS Syphilis in Pregnancy Guideline

10.2.2 Late syphilis in pregnancy and syphilis of unknown duration (all three trimesters) . 14 10.2.3 Neurosyphilis (all trimesters) 14 10.3 Special considerations 15 10.3.1 Syphilis infection treated prior to pregnancy 15 10.3.2 Penicillin allergy 15 10.3.3 Syphilis diagnosis > 20 weeks of pregnancy 16 10.3.4 Jarisch-Herxheimer (JH) reaction 16 10.3.5 HIV positive pregnant woman with syphilis 17 10.3.6 Management of sexual contacts and other children 17 Syphilis in Pregnancy Sept 2020 V1 3 Table 2 (...) 17 10.3.7 Management of pregnant sexual contacts of infectious syphilis 17 10.3.8 Follow up 18 10.3.9 Labour and birth 19 10.3.10 Contact Precautions 19 10.3.11 Handling of placenta (whenua) 19 11. Care of the new-born (birth to 1 month) 20 11.1 Infant assessment and management summary (infants 2 years since acquisition with no symptoms) and tertiary syphilis (symptomatic late syphilis e.g. gummas, cardiovascular and neurological involvement). Syphilis in Pregnancy Sept 2020 V1 8 Primary syphilis

2020 New Zealand Sexual Health Society

66. Coronavirus (COVID-19) infection and pregnancy

Coronavirus (COVID-19) infection and pregnancy 1 Information for healthcare professionals Version 9: Published Wednesday 13 May 2020 Coronavirus (COVID-19) Infection in Pregnancy2 Contents Summary of updates 3-5 1. Introduction 6-11 2. Advice for health professionals to share with pregnant women 12-19 3. Advice for all midwifery and obstetric services caring for pregnant women 20-36 4. Advice for services caring for women with suspected or confirmed COVID-19 37-39 Acknowledgements 40 Appendix 1 (...) for antibiotics at presentation, with early review and rationalisation of antibiotics if COVID-19 is confirmed.’ 9 13.5.20 3.6: Statement added: ‘A woman with moderate or severe COVID symptoms who happens to be pregnant but with no immediate pregnancy issue should be cared for by the same multidisciplinary team as a non-pregnant woman with additional input from the maternity team. The labour ward should not be the default location for all pregnant women.’6 1. Introduction7 1. Introduction The following advice

2020 Royal College of Obstetricians and Gynaecologists

67. Association of Migraine Headaches With Suicidal Ideation Among Pregnant Women in Lima, Peru. Full Text available with Trip Pro

with increased odds of suicidal ideation in pregnant women even when controlling for depression. These findings support the consideration of screening women with comorbid migraine and depression for suicidal behavior during pregnancy.© 2016 American Headache Society. (...) Association of Migraine Headaches With Suicidal Ideation Among Pregnant Women in Lima, Peru. Suicide is a leading cause of maternal death globally, and suicide prevalence rates have been shown to be increased in those with migraine. No previous study has examined the association between migraine and suicidal ideation during pregnancy.To examine the association between migraine and suicidal ideation among a cohort of pregnant women.A cross-sectional study was conducted among 3372 pregnant women

2016 Headache

68. A Pregnant Woman with Headache

A Pregnant Woman with Headache Rotation Prep | NEJM Resident 360 Social Login Email Login Log in via Email Create Your Account We will not share your email with anyone. Password must be at least 8 characters. Show or Hide the password you are typing. Request to Join has invited you to join this group Your browser does not support video tags Welcome! NEJM Resident 360 helps you prepare for your next rotation quickly and efficiently, provides support for coping with the pressures of resident life

2015 Now@NEJM

69. Towards integrated antenatal care for low-risk pregnancy

of the pregnancy What you need to know before reading this section This section is based on data coming from various sources: The Planning Unit for Healthcare Professions Workforce within the Federal Public Service Public Health provided statistics related to healthcare professionals on 31 December 2017 (head counts and full- time equivalents [FTE]); The care consumption is described using AIM/IMA administrative data related to (insured) pregnant women’s characteristics (age, residence, insurance coverage (...) engaged in non-clinical interventions 28 3.2.4 How to improve BPPE: Literature review and stakeholders consultation 28 3.3 ICT INNOVATIONS FOR INFORMATION EXCHANGE 31 4 LEGAL FRAMEWORK OF ANC AND PROTECTIVE MEASURES FOR PREGNANT WOMEN IN BELGIUM 33 4.1 LEGAL FRAMEWORK OF ANC IN BELGIUM 33 4.2 PROTECTIVE MEASURES FOR (VULNERABLE) PREGNANT WOMEN 34 2 Towards integrated antenatal care for low-risk pregnancy KCE Report 326 5 PROVISION AND UPTAKE OF ROUTINE ANC: PARENTS’ AND HEALTHCARE PROFESSIONALS

2020 Belgian Health Care Knowledge Centre

70. The Effect of Sumatriptan and Placebo on CGRP Induced Headache

. Exclusion Criteria: Healthy: Any type of headache (except episodic tension-type headache < 1 day per week) Serious somatic or psychiatric disease Pregnancy Intake of daily medication (except oral contraceptives). Migraine patients: Any other type of headache then migraine without aura (except episodic tension-type headache < 1 day per week) Serious somatic or psychiatric disease Pregnancy Intake of daily medication (except oral contraceptives) Triptan non-responders Contacts and Locations Go (...) Product: No Studies a U.S. FDA-regulated Device Product: No Additional relevant MeSH terms: Layout table for MeSH terms Headache Pain Neurologic Manifestations Signs and Symptoms Sumatriptan Calcitonin Katacalcin Calcitonin Gene-Related Peptide Vasoconstrictor Agents Serotonin 5-HT1 Receptor Agonists Serotonin Receptor Agonists Serotonin Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs Calcium-Regulating Hormones and Agents Bone Density

2017 Clinical Trials

71. Capsaicin in Treatment of Rhinogenic Headache

Medical center complaining of headaches/ facial pain and pressure Diagnosis of a primary rhinogenic headache disorder by the senior authors. Exclusion Criteria: Exclusion criteria include: pregnancy, age less than 19, active history of smoking, presence of confirmed sinonasal disease, fibromyalgia, poorly controlled chronic health problems, allergies to chili peppers or any ingredient in the nasal spray, or confirmed Temporal Mandibular Joint (TMJ) arthralgia as the etiology of primary headache (...) to receive two bottles of either eucalyptol spray (placebo) or sinus buster (capsaicin) spray and are blinded to the content of the spray bottle. They are instructed to use the nasal spray one to two times daily. Subjects are permitted to continue to take headache medication as needed, but it must be recorded in their symptom journal. The journal is completed daily, and includes medication use, a headache pain score, and side effect log. Additionally, subjects fill out SinoNasal Outcome test (SNOT)22

2017 Clinical Trials

72. Psilocybin for the Treatment of Migraine Headache

test session ] Measured in days Change in migraine attack frequency [ Time Frame: From two weeks before first session to two weeks after second session using a headache diary ] Average number (number per week) Change in migraine attack duration [ Time Frame: From two weeks before first session to two weeks after second session using a headache diary ] Average duration (measured in hours) Change in pain intensity of migraine attacks [ Time Frame: From two weeks before first session to two weeks (...) after second session using a headache diary ] Average pain intensity (4-tiered pain score; 1=none, 2=mild, 3=moderate, 4=severe) Change in intensity of nausea/vomiting during migraine attacks [ Time Frame: From two weeks before first session to two weeks after second session using a headache diary ] Average intensity (4-tiered pain score; 1=none, 2=mild, 3=moderate, 4=severe) Change in intensity of photophobia [ Time Frame: From two weeks before first session to two weeks after second session using

2017 Clinical Trials

73. Managing MTBI-related Headaches With rTMS

Scale score of 13-15 post-traumatic amnesia not greater than 24 hrs In addition, the following established diagnostic criteria for " Persistent headache attributed to mild traumatic injury headache" based on the International Classification of Headache Disorder (ICHD-3) will be applied to the study subjects: A. Any headache fulfilling criteria C and D B. Traumatic injury to the head has occurred C. Headache is reported to have developed within 7 d after one of the following: 1. injury to the head 2 (...) . regaining of consciousness following the injury 3. discontinuation of medication(s) that impairs the ability to sense or report headache following the injury D. Headache persists for >3 mo after injury to the head E. Not better accounted for by another ICHD-3 diagnosis Additional Inclusion Criteria: no prior experience of TMS treatment average persistent headache intensity more than 30 on the 0-100 mechanical visual analog scale(M-VAS) at the screening visit (visit 1)[64] and average persistent headache

2017 Clinical Trials

74. Headache After Coil Embolization for Unruptured Intracranial Aneurysms

tumor pregnant patients patients with past history that may associated with headache, including subarachnoid hemorrhage, head trauma, intracerebral hemorrhage, trigeminal neuralgia, arteriovenous malformation, brain tumor) Patients who are determined to be disqualified by researchers Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided (...) Device Product: No Keywords provided by Seoul National University Hospital: coil embolization headache stent Additional relevant MeSH terms: Layout table for MeSH terms Aneurysm Headache Intracranial Aneurysm Vascular Diseases Cardiovascular Diseases Pain Neurologic Manifestations Signs and Symptoms Intracranial Arterial Diseases Cerebrovascular Disorders Brain Diseases Central Nervous System Diseases Nervous System Diseases

2017 Clinical Trials

75. The Effect of Botulinum Toxin A on Headache Attributed to TMD

to TMD based on Diagnostic Criteria for TMD (DC-TMD) criteria. A minimum of 15 headaches/events per month, for the last 3 months. Average pain intensity in the last month of ≥5 (0 to 10 scale) where 0 is no pain and 10 is the worst pain ever. Exclusion Criteria: Pregnancy Participants with a history of neurological/neuromuscular disorders and bleeding disorders. Participants taking prescribed analgesics, muscle relaxants, amino glycosides, or anticholinesterases. Participants currently under BTX (...) will be seen for a total of 4 visits and 3 phone interviews. Participants will complete a set of self-reporting questionnaires, assessing the disability associated with Headaches Attributed to TMD, and other pain-related TMD diagnoses, the impact of headaches on the quality of life, and psychosocial distress questionnaires. In addition, they will undergo 3 cycles of treatment, each 12 weeks apart. Other Name: Botox Outcome Measures Go to Primary Outcome Measures : Reduction in number of Headaches

2017 Clinical Trials

76. Medical Undergraduate Survey on Headache Education in Singapore: Knowledge, Perceptions, and Assessment of Unmet Needs. (Abstract)

population groups diagnosed with migraine - pregnant (79.5%), elderly (48.0%), those with cardiac conditions (51.2%).The current medical undergraduate curriculum on headache disorders in Singapore may harbor significant unmet needs. A review of the syllabus to increase headache education may be one method to address this gap. Further studies in this area are required.© 2017 American Headache Society. (...) Medical Undergraduate Survey on Headache Education in Singapore: Knowledge, Perceptions, and Assessment of Unmet Needs. There have been no prior studies assessing the status of undergraduate headache training and education in Singapore. Unmet needs of undergraduate medical students in terms of knowledge-practice gaps pertaining to diagnosis and management of headache disorders are unknown. The possible underemphasis of this aspect of the curriculum as compared to other chronic conditions

2017 Headache

77. Postdural puncture headache Full Text available with Trip Pro

Postdural puncture headache Postdural puncture headache (PDPH) is a common complication after inadvertent dural puncture. Risks factors include female sex, young age, pregnancy, vaginal delivery, low body mass index, and being a non-smoker. Needle size, design, and the technique used also affect the risk. Because PDPH can be incapacitating, prompt diagnosis and treatment are mandatory. A diagnostic hallmark of PDPH is a postural headache that worsens with sitting or standing, and improves

2017 Korean journal of anesthesiology

78. The Sphenopalatine Ganglion Block for Post-dural Puncture Headache

downward traction on the meninges with parasympathetic ally mediated reflex vasodilation of the meningeal vessels. The epidural blood patch is currently the gold-standard treatment for postdural puncture headache, however it is an invasive procedure with possible risks and complications including bleeding, infection, pain, hematoma, neurologic complications, and repeat dural puncture. Patients are often offered conservative treatment including medications, bed rest, abdominal binders, and fluids (...) , with head in sniffing position. Two long cotton-tipped applicators will be soaked in 4% lidocaine for 30 seconds. An anesthesia provider, after visually inspecting each nostril for any sign of deformity or blockage, will perform the block. A cotton tipped applicator will be inserted into one nostril at an angle perpendicular to the face, and will be advanced to the back of the nasopharynx until resistance is met. The procedure will be repeated in the other nostril. If the patient experiences any pain

2017 Clinical Trials

79. Carbon Monoxide Headache Triggering Properties as Well as Effects on the Brain's Vessels and Blood Flow

headaches Daily medication except contraceptives Drug taken within 4 times the halflife for the specific drug except contraceptives Pregnant or lactating women Exposure to radiation within the last year Headache within the last 24 hours before start of trial Hypertension Hypotension Respiratory or cardiac disease Smoking Primary relatives with current or previous migraine Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may (...) Identifier: Other Study ID Numbers: H-17016387 First Posted: December 28, 2017 Last Update Posted: March 13, 2018 Last Verified: March 2018 Layout table for additional information Studies a U.S. FDA-regulated Drug Product: No Studies a U.S. FDA-regulated Device Product: No Additional relevant MeSH terms: Layout table for MeSH terms Headache Headache Disorders Pain Neurologic Manifestations Signs and Symptoms Brain Diseases Central Nervous System Diseases Nervous System Diseases Carbon Monoxide

2017 Clinical Trials

80. Evaluation of a Novel Device for Treatment of Migraine Headache

conditioned pain modulation (CPM). CPM an stimulate endogenous analgesic mechanism. The modulatory effect is over the whole body, and can be induced anywhere. This is a prospective, randomized, double-blind, sham controlled multi-center trial. Ratio between treatment and control groups will be 1:1, stratified by center and use of preventive medications. The study objectives is to demonstrate the safety and effectiveness of the Nerivio Migra electro stimulation device for the reduction of migraine headache (...) during an attack of migraine with or without aura. The study is intended for subject with 2-8 migraine episodes per month. patients will receive the device, either an active or a placebo type, and will be asked to use the device at home or in any location that they will be when the migraine starts. The study hypothesis is that electro stimulation delivered transcutaneously to the peripheral nervous system at onset of a migraine attack significantly reduce headache pain demonstrated by a significant

2017 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>